Advanced search
Publication Cover
Future Oncology Volume 16, 2020 - Issue 3
Submit an article Journal homepage
1,623
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka1 The Anticancer Fund, 1853 Strombeek-Bever, Brussels, Belgium;2 The George Pantziarka TP53 Trust, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4676-7835
ORCID Icon,
Ciska Verbaanderd1 The Anticancer Fund, 1853 Strombeek-Bever, Brussels, Belgium;3 Clinical Pharmacology & Pharmacotherapy,Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Belgium
&
Lydie Meheus1 The Anticancer Fund, 1853 Strombeek-Bever, Brussels, Belgium
Pages 4419-4423 | Received 20 Nov 2019, Accepted 27 Nov 2019, Published online: 11 Dec 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jaime A Teixeira da Silva. (2022) Issues and Challenges to Reproducibility of Cancer Research: A Commentary. Future Oncology 18:12, pages 1417-1422.
Read now
Marc Sorigue & Outi Kuittinen. (2021) Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma. Expert Review of Hematology 14:7, pages 655-668.
Read now

Articles from other publishers (1)

Etienne Lengliné, Julien Peron, Antoine Vanier, François Gueyffier, Serge Kouzan, Patrick Dufour, Bernard Guillot, Hugues Blondon, Michel Clanet, Pierre Cochat, Françoise Degos, Sylvie Chevret, Mathilde Grande & Jade Putzolu. (2021) Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment. The Lancet Oncology 22:10, pages e430-e434.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.